Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper

Immunotherapy with checkpoint inhibitors against programmed cell death receptor (PD-1) and programmed cell death ligand (PD-L1) has been implemented in the treatment pathway of patients with non-small cell lung cancer (NSCLC) from locally advanced disease to the metastatic setting. This approach has...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Fabio, Wong, Melisa, Battisti, Nicolò Matteo Luca, Kordbacheh, Tiana, Kiderlen, Mandy, Greystoke, Alastair, Luciani, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492214/
https://www.ncbi.nlm.nih.gov/pubmed/32694695
http://dx.doi.org/10.1038/s41416-020-0986-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492214/
https://www.ncbi.nlm.nih.gov/pubmed/32694695
http://dx.doi.org/10.1038/s41416-020-0986-4

Ejemplares similares